These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 7693985)
21. Magnetic resonance spectroscopy detects metabolic differences between seven Dunning rat prostate tumor sublines with different biological behavior. Cornel EB; Heerschap A; Smits GA; Oosterhof GO; Debruyne FM; Schalken JA Prostate; 1994 Jul; 25(1):19-28. PubMed ID: 8022708 [TBL] [Abstract][Full Text] [Related]
22. Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases. Ling D; Lee JK; Heiken JP; Balfe DM; Glazer HS; McClennan BL Radiology; 1986 Jan; 158(1):103-7. PubMed ID: 2416005 [TBL] [Abstract][Full Text] [Related]
23. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India. Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926 [TBL] [Abstract][Full Text] [Related]
24. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Kurhanewicz J; Vigneron DB; Hricak H; Parivar F; Nelson SJ; Shinohara K; Carroll PR Radiology; 1996 Aug; 200(2):489-96. PubMed ID: 8685346 [TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance spectroscopy in prostate disease: diagnostic possibilities and future developments. Narayan P; Kurhanewicz J Prostate Suppl; 1992; 4():43-50. PubMed ID: 1374177 [TBL] [Abstract][Full Text] [Related]
26. MR characteristics of prostatic carcinoma and benign prostatic hyperplasia at 1.5 T. Griebel J; Hess CF; Schmiedl U; Koelbel G J Comput Assist Tomogr; 1988; 12(6):988-94. PubMed ID: 2460511 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of the prostate by magnetic resonance imaging. Larkin BT; Berquist TH; Utz DC Magn Reson Imaging; 1986; 4(1):53-8. PubMed ID: 2419725 [TBL] [Abstract][Full Text] [Related]
28. [Spectroscopic imaging (1H-2D-CSI) of the prostate: sequence optimization and correlation with histopathological results]. Stanka M; Eltze E; Semjonow A; Sievert KD; Maier A; Pfleiderer B Rofo; 2000 Jul; 172(7):623-9. PubMed ID: 10962989 [TBL] [Abstract][Full Text] [Related]
29. Detection and staging of prostatic carcinoma after transurethral resection or open enucleation of the prostate: accuracy of magnetic resonance imaging. Carroll PR; Sugimura K; Cohen MB; Hricak H J Urol; 1992 Feb; 147(2):402-6. PubMed ID: 1370698 [TBL] [Abstract][Full Text] [Related]
30. Proton magnetic resonance spectroscopy of the central, transition and peripheral zones of the prostate: assignments and correlation with histopathology. Swindle P; Ramadan S; Stanwell P; McCredie S; Russell P; Mountford C MAGMA; 2008 Nov; 21(6):423-34. PubMed ID: 18797949 [TBL] [Abstract][Full Text] [Related]
31. Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study. Kurhanewicz J; Dahiya R; Macdonald JM; Chang LH; James TL; Narayan P Magn Reson Med; 1993 Feb; 29(2):149-57. PubMed ID: 8429778 [TBL] [Abstract][Full Text] [Related]
32. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age? Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863 [TBL] [Abstract][Full Text] [Related]
33. Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer. van der Graaf M; Schipper RG; Oosterhof GO; Schalken JA; Verhofstad AA; Heerschap A MAGMA; 2000 Jul; 10(3):153-9. PubMed ID: 10873205 [TBL] [Abstract][Full Text] [Related]
34. Proton MR T2 maps correlate with the citrate concentration in the prostate. Liney GP; Lowry M; Turnbull LW; Manton DJ; Knowles AJ; Blackband SJ; Horsman A NMR Biomed; 1996 Apr; 9(2):59-64. PubMed ID: 8887369 [TBL] [Abstract][Full Text] [Related]
35. [Magnetic resonance spectroscopy of the prostate: a description of the methodology and the own results]. Kitaev SV; Morozov SP; Zhivov AV Urologiia; 2014; (5):40-7. PubMed ID: 25807758 [TBL] [Abstract][Full Text] [Related]
36. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma. Hussein MR; Al-Assiri M; Musalam AO Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537 [TBL] [Abstract][Full Text] [Related]
37. Differentiation of human tumors from nonmalignant tissue by natural-abundance 13C NMR spectroscopy. Halliday KR; Fenoglio-Preiser C; Sillerud LO Magn Reson Med; 1988 Aug; 7(4):384-411. PubMed ID: 2459580 [TBL] [Abstract][Full Text] [Related]
39. [Clinical study on prostatic cancer detected incidentally by transurethral resection of the prostate]. Hayakawa T; Mitsuya H; Kojima M; Hayase Y Hinyokika Kiyo; 2002 Jan; 48(1):13-6. PubMed ID: 11868378 [TBL] [Abstract][Full Text] [Related]
40. Single-voxel oversampled J-resolved spectroscopy of in vivo human prostate tissue. Swanson MG; Vigneron DB; Tran TK; Sailasuta N; Hurd RE; Kurhanewicz J Magn Reson Med; 2001 Jun; 45(6):973-80. PubMed ID: 11378874 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]